Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11469 posts found.

Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101

April 3, 2023 Sales and Marketing

Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …
News

Alzheimer’s drug Leqembi expected to generate $12.9bn in sales by 2028

March 30, 2023 Sales and Marketing

After receiving FDA approval in January 2023, Biogen/Eisai’s new Alzheimer’s disease Leqembi is expected to become a blockbuster, with a …
News

PureTech Health and Royalty Pharma enter KarXT royalty agreement up to $500m

March 23, 2023 Sales and Marketing

Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and …
News

BioNTech and OncoC4 to partner for development and commercialisation of novel checkpoint antibody

March 21, 2023 Sales and Marketing

BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple …
News

Sun Pharma settles at $75m in industry-wide price-fixing case

March 17, 2023 Sales and Marketing

Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices. …
News

Sanofi to cut insulin prices by 78% starting January 2024

March 17, 2023 Sales and Marketing

French pharmaceutical company Sanofi has announced that it will cut the list price of its Lantus (insulin glargine injection) 100 …
News

The Association of the British Pharmaceutical Industry suspends Novo Nordisk for two years

March 16, 2023 Sales and Marketing

The Association of the British Pharmaceutical Industry (ABPI) has suspended Danish pharmaceutical company Novo Nordisk after “serious breaches” of the …
News

Novo Nordisk to cut insulin prices by up to 75% in 2024

March 15, 2023 Sales and Marketing

Danish pharmaceutical company Novo Nordisk has announced that it will cut its prices for insulin products by up to 75%, …
News

Pfizer signs $43bn deal to buy Seagen

March 14, 2023 Sales and Marketing

Pharma giant Pfizer has signed a definitive merger agreement valued at $43bn to buy biotech firm Seagen.   US-based Seagen …
News

Sanofi to acquire Provention Bio in $2.9bn deal

March 13, 2023 Sales and Marketing

Sanofi has agreed to acquire Provention Bio as part of a $2.9bn deal that aims to improve the company’s portfolio …
News

Gilead Sciences wins $175m in ongoing HIV fraud case

March 13, 2023 Sales and Marketing

Gilead Sciences, a research-based biopharmaceutical company, has won again in the lawsuit levelled against clinics, prescribers, medical labs and pharmacies …
News

FDA makes unusual ‘misinformation’ comment on Lucira’s EUA for COVID-19 and flu test

March 10, 2023 Sales and Marketing

The FDA has made a rare comment about what happened at Lucira Health’s Emergency Use Authorization (EUA) filing for its …
News

GSK’s RSV vaccine ready to launch

March 9, 2023 Sales and Marketing

GSK has announced that it is ready to launch its respiratory syncytial virus (RSV) vaccine in the US at some …
News

Funding to increase access to early phase clinical trials given to Yale Cancer Center

March 7, 2023 Sales and Marketing

Yale Cancer Center has announced it has received collaborative funding aiming to support and increase access to early phase clinical …
News

Eli Lilly signs $40m licensing deal with Confo Therapeutics over neuropathic pain treatment

March 3, 2023 Sales and Marketing

US-based pharmaceutical company Eli Lilly has signed a small licensing deal with Belgian start-up Confo Therapeutics to allow them access …
News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024